Conference call to be held on Thursday, March 30 at 8:30 a.m. ET
ROCKVILLE, Md., March 24, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it plans to host a conference call on Thursday, March 30, 2023, at 8:30 a.m. ET to discuss its financial results for the fourth quarter and full-year ended December 31, 2022 and provide a corporate update. The call was originally scheduled for Monday, March 27, 2023, at 8:30 a.m. ET.
Individuals may participate in the live call via telephone by dialing 1-877-451-6152, under "Events" or by clicking here, up to 90 days after the call.
About Theriva Biologics, Inc.
Theriva Biologics.
For further information, please contact:
Investor Relations:
Chris Calabrese
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com
917-680-5608
